Secondly, researchers have shown that it is likely that people with helminth infections and type 2 immune responses might have a higher risk for both non-IgE-mediated and IgE-mediated anaphylaxis upon receiving the first vaccine dose and or booster doses, respectively [77]. This evidence concerns the gene IGHE and anaphylaxis.